| ACE | Angiotensin-Converting Enzyme |
| ACH | Acetylcholine |
| ACTH | Adrenocorticotropic Hormone |
| BDNF | Brain-Derived Neurotrophic Factor |
| BSH | Bile Salt Hydrolase |
| CNS | Central Nervous System |
| CVD | Cardiovascular Disease |
| DCs | Dendritic Cells |
| EPS | Exopolysaccharides |
| ENS | Enteric Nervous System |
| FDA | US Food and Drug Administration |
| FFAR2 | Free Fatty Acid Receptor 2 |
| FFAR3 | Free Fatty Acid Receptor 3 |
| GI | Glycemic Index |
| GLP-1 | Glucagon-Like Peptide-1 |
| GSH-Px | Glutathione Peroxidase |
| GRAS | Generally Regarded As Safe |
| HDL | High-Density Lipoprotein |
| HMG-CoA | 3-Hydroxy-3-Methylglutaryl-Coenzyme A |
| HPA | Hypothalamic–Pituitary–Adrenal Axis |
| IL | Interleukin |
| ISAPP | International Scientific Association for Probiotics and Prebiotics |
| LAB | Lactic acid bacteria |
| LDL | Low-Density Lipoprotein |
| LPS | Lipopolysaccharide |
| LTA | Lipoteichoic Acid |
| MDD | Major Depressive Disorder |
| MGBA | Microbiota–Gut–Brain Axis |
| MUBs | Mucus-Binding Proteins |
| NCD | Non-Communicable Disease |
| NF-κB | Nuclear Factor Kappa-B |
| NK | Natural Killer |
| QPS | Qualified Presumption of Safety |
| PPAR | Peroxisome Proliferator-Activated Receptor |
| PRRs | Pattern Recognition Receptors |
| SLP | Surface Layer Protein |
| TGF-β | Transforming Growth Factor Beta |
| Th | T-Helper Cells |
| TLR | Toll-Like Receptor |
| TNF-α | Tumor Necrosis Factor-alpha |
| USP | United States Pharmacopeia |